<i>Schistosoma haematobium</i> prevalence in hotspot implementation units (IUs) in annual school-based surveys (A) and household-based surveys (B) of the SchistoBreak study in Pemb... by Lydia Trippler (10136316)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

<i>Schistosoma haematobium</i> and microhematuria prevalence. by Lydia Trippler (10136316)

Subjects:

Annual change in low-prevalence (orange) and hotspot (red) implementation units (IUs). by Lydia Trippler (10136316)

Subjects:

Chance of infection with <i>Schistosoma haematobium.</i> by Lydia Trippler (10136316)

Subjects:

Study participation. by Lydia Trippler (10136316)

Subjects:

Microhematuria prevalence in hotspot implementation units. by Lydia Trippler (10136316)

Subjects:

Interventions in the hotspot implementation units (IUs). Interventions in the hotspot IUs of the SchistoBreak study in three intervention periods in Pemba, Tanzania, from 2021 to 2... by Lydia Trippler (10136316)

Subjects:

Microbial differential abundance at 24 hours post-treatment was assessed using ANCOM (<i>P</i> <  0.05). by Elena G. Olson (10649705)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

S6 Dataset - by Rahmat Naddafi (373065)

Subjects:

Characteristics of patients with abnormal lung function whose severity classification changed when the <i>z</i>-score guidelines from 2022 were applied in comparison to those who w... by Piotr W. Boros (21446186)

Hazard ratios (HR) for all-cause mortality with 95% confidence intervals from Cox regression models using the 2005 vs. the 2022 guidelines for grading severity, normal FVC (<i>n</i... by Piotr W. Boros (21446186)

The primer sequence used in this study. by Yu Zhang (12946)

Subjects:

The functional enrichment of the glucocorticoid signaling-related genes showing differential expression through the Metascape. by Yu Zhang (12946)

Subjects:

The baseline clinicopathological features of the public and local KIRC cohorts. by Yu Zhang (12946)

Subjects: